Member Info for BigDano

Abingdon can't be too far away from completing TT. This was possibility deprioritised due to other challenges since the parnership announcement was made but now likely back in focus as Abingdon will be actively looking to secure capacity for their new facilities . That new capacity of theirs isn't going to be taken up by the government at present with the current court case.

Thanks Scardey. Do keep us posted.

It can't be too far away from medusa announcing their usability tests too.... I guess there's no chance that they would share an update..

Convex hats off to you, fantastic research. Thanks for your valuable insights and diligent work.

And a little reminder that UU are also involved in the RTC user testing for antibodies, see tweets from back in May by the same point of contact for vistic usability testing :- Tara Moore..

https://twitter.com/tara_moore7/status/1396117913573150729?s=19

According to their (intermedicalss)website they are a partner of a much bigger group:

https://www.quironsalud.es/en/informacion-pruebas-covid#ANTIGENO

Technically they have 4 outlets according to their website. Reasonably priced in comparison to the other tests they offer too.

The parnership announced with screen4 is only for antibody testing but hopefully the parnership can be expanded in the near future to include other testing services

Definitely nothing happening at Alva on weekends..

https://twitter.com/moneyroots1234/status/1426520427405447170?s=19

Any insights/updates on BAMS, included a snippet from the June 2020 RNS but has there been any further updates from the company that has been issued?.

We are now looking forward to testing the prototype BAMS assay with patient samples in the UK very soon, whilst Adeptrix does the same at a site in the US. This will keep us on track for launch of a product for professional use in the summer.



A COVID-19 BAMS assay could provide highly sensitive and specific testing for up to a thousand samples per day in the hospital setting using standard equipment that is available but not currently used for coronavirus testing thus contributing significantly to an increase in global testing capacity.

We also have payments from licensing agreements as they come on stream , for example the POINT licensing agreement from Jan's RNS is:

'Under the terms of the agreement, Avacta will receive an upfront fee and development milestones for the first radiopharmaceutical prodrug totalling $9.5 million'

Good to see things are rather busy at Alva...

https://twitter.com/moneyroots1234/status/1426138770965942280?s=19

https://www.bbc.co.uk/news/business-58137461

US cases surging from an article in todays guardian.https://www.theguardian.com/world/2021/aug/06/us-covid-coronavirus-delta-variant?CMP=Share_AndroidApp_Other"About half of all new infections and hospitalizations in the past week were in seven southern states – Florida, Texas, Missouri, Arkansas, Louisiana, Alabama and Mississippi – even though the states represent less than a quarter of the country’s population, said White House coronavirus coordinator, Jeff Zients.In Mississippi on Thursday, there were 3,164 new confirmed cases, the second highest single-day caseload in the state during the pandemic."Pity we only have 4 sites up and running in the states, do we know if more are going to come on stream?. https://clinicaltrials.gov/ct2/history/NCT04732949?A=4&B=5&C=Side-by-Side#StudyPageTop

Seaboy hats off to you. Thank you for taking the time out to write such a comprehensive update and for the great work you and colleagues are doing.

The write up is so informative that you should consider tweeking it to be a blog post as many would be interested in the challenges your facing on the front line. Stay safe and keep the amazing work.

Nice one confidentials and impressive number of twitter followers too ( thumbs up).

Have we had any updates from Avacta on Bams in recent months or where are we at exactly?.

Interestingly the Abdx RNS included the following paragraph

Importantly, due to the utility of the score card used alongside the AbC-19TM test for these applications, Abingdon intends to make a supplementary product available, initially for research use only, in August which provides a semi-quantitative result which will may indicate the strength of antibody response and possibly immunity."

Been a few weeks since the user trials, any views on how long it takes before they publicise the results?

Based on the ODX presentation we should see movement with RTC confirmed orders from a couple of countries in the next few weeks

4.30 presentation must be a first for ODX..

It's been over 12 months, surely an update on how this roll out is going in the upcoming results meeting...

https://www.clintonhealthaccess.org/unitaid-and-chai-announce-agreement-with-omega-diagnostics-to-increase-access-to-new-portable-cd4-testing-device-for-people-living-with-hiv-in-over-130-low-and-middle-income-countries/